Biomark Diagnostics Inc. (FRA:20B)
Germany · Delayed Price · Currency is EUR 0.3280
-0.0080 (-2.38%)
Last updated: Feb 23, 2026, 8:20 AM CET
Biomark Diagnostics Market Cap
Biomark Diagnostics has a market cap or net worth of €35.31 million as of February 23, 2026. Its market cap has increased by 213.32% in one year.
Market Cap
35.31M
Enterprise Value
34.85M
Revenue
75.52K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.33
Market Cap Chart
Since November 27, 2014, Biomark Diagnostics's market cap has increased from 28.50M to 35.31M, an increase of 23.91%. That is a compound annual growth rate of 1.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 35.31M | 8.39% |
| Dec 30, 2025 | 32.58M | 228.85% |
| Dec 30, 2024 | 9.91M | -19.08% |
| Dec 29, 2023 | 12.24M | 23.53% |
| Dec 30, 2022 | 9.91M | -23.89% |
| Dec 30, 2021 | 13.02M | 134.71% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PEH Wertpapier AG | 48.36M |
| Fernheizwerk Neukölln Aktiengesellschaft | 46.46M |
| Fair Value REIT-AG | 43.77M |
| Enapter AG | 43.23M |
| SBF AG | 43.10M |
| BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- | 42.24M |
| U.C.A. Aktiengesellschaft | 39.27M |
| OTRS AG | 36.22M |